{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:56:37Z","timestamp":1778975797392,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical trials and studies with ivabradine implicate cardiac pacemaker channels (HCN4) in the pathogenesis of atrial arrhythmias. Because acute changes in cardiac autonomic tone predispose to atrial arrhythmias, we studied humans in whom profound cardiac sympathetic activation was rapidly relieved to test influences of HCN4 inhibition with ivabradine on atrial arrhythmias. We tested 19 healthy participants with ivabradine, metoprolol, or placebo in a double blind, randomized, cross-over fashion on top of selective norepinephrine reuptake inhibition with reboxetine. Subjects underwent combined head up tilt plus lower body negative pressure testing followed by rapid return to the supine position. In the current secondary analysis with predefined endpoints before data unblinding, continuous finger blood pressure and ECG recordings were analyzed by two experienced cardiac electrophysiologists and a physician, blinded for treatment assignment. The total atrial premature activity (referred to as atrial events) at baseline did not differ between treatments. After backwards tilting, atrial events were significantly higher with ivabradine compared with metoprolol or with placebo. Unlike beta-adrenoreceptor blockade, HCN4 inhibition while lowering heart rate does not protect from atrial arrhythmias under conditions of experimental cardiac sympathetic activation. The model in addition to providing insight in the role of HCN4 in human atrial arrhythmogenesis may have utility in gauging potential atrial pro-arrhythmic drug properties.<\/jats:p>","DOI":"10.1038\/s41598-018-26099-9","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T09:20:30Z","timestamp":1526030430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation"],"prefix":"10.1038","volume":"8","author":[{"given":"Kristine","family":"Chobanyan-J\u00fcrgens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-5585","authenticated-orcid":false,"given":"Karsten","family":"Heusser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-6338","authenticated-orcid":false,"given":"David","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Veltmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-4244","authenticated-orcid":false,"given":"Marcus","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Mehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich C.","family":"Luft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5672-1187","authenticated-orcid":false,"given":"Jens","family":"Tank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"26099_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1540-8167.1996.tb00474.x","volume":"7","author":"P Coumel","year":"1996","unstructured":"Coumel, P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 7, 999\u20131007 (1996).","journal-title":"J Cardiovasc Electrophysiol."},{"key":"26099_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1540-8167.2001.00285.x","volume":"12","author":"M Zimmermann","year":"2001","unstructured":"Zimmermann, M. & Kalusche, D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol. 12, 285\u2013291 (2001).","journal-title":"J Cardiovasc Electrophysiol."},{"key":"26099_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-006-0611-6","volume":"102","author":"M Hirose","year":"2007","unstructured":"Hirose, M. & Imamura, H. Mechanisms of atrial tachyarrhythmia induction in a canine model of autonomic tone fluctuation. Basic Res Cardiol. 102, 52\u201362 (2007).","journal-title":"Basic Res Cardiol."},{"key":"26099_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0002-9149(98)00231-8","volume":"82","author":"C Dimmer","year":"1998","unstructured":"Dimmer, C. et al. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 82, 22\u201325 (1998).","journal-title":"Am J Cardiol."},{"key":"26099_CR5","first-page":"3291","volume":"36","author":"K Fox","year":"2015","unstructured":"Fox, K. et al. SIGNIFY investigators. Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. Eur Heart J. 36, 3291\u20133296 (2015).","journal-title":"Eur Heart J."},{"key":"26099_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/clc.22578","volume":"39","author":"\u0130H Tanbo\u011fa","year":"2016","unstructured":"Tanbo\u011fa, \u0130. H. et al. The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients. Clin Cardiol. 39, 615\u2013620 (2016).","journal-title":"Clin Cardiol."},{"key":"26099_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.hrthm.2014.03.002","volume":"11","author":"V Macri","year":"2014","unstructured":"Macri, V. et al. A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation. Heart Rhythm. 11, 1055\u20131062 (2014).","journal-title":"Heart Rhythm."},{"key":"26099_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/clpt.2014.25","volume":"95","author":"C Schroeder","year":"2014","unstructured":"Schroeder, C. et al. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study. J. Clin Pharmacol Ther. 95, 601\u2013607 (2014).","journal-title":"J. Clin Pharmacol Ther."},{"key":"26099_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/hc0302.102597","volume":"105","author":"C Schroeder","year":"2002","unstructured":"Schroeder, C. et al. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation. 105, 347\u2013353 (2002).","journal-title":"Circulation."},{"key":"26099_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI111939","volume":"76","author":"DS Goldstein","year":"1985","unstructured":"Goldstein, D. S. et al. Measurement of regional neuronal removal of norepinephrine in man. J Clin Invest. 76, 15\u201321 (1985).","journal-title":"J Clin Invest."},{"key":"26099_CR11","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1161\/01.CIR.0000072786.99163.FE","volume":"107","author":"J Tank","year":"2003","unstructured":"Tank, J. et al. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation. 107, 2949\u201354 (2003).","journal-title":"Circulation."},{"key":"26099_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1359786806066055","volume":"20","author":"M Esler","year":"2006","unstructured":"Esler, M. et al. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol. 20, 60\u20136 (2006).","journal-title":"J Psychopharmacol."},{"key":"26099_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.CIR.78.1.41","volume":"78","author":"DS Goldstein","year":"1988","unstructured":"Goldstein, D. S., Brush, J. E. Jr., Eisenhofer, G., Stull, R. & Esler, M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation. 78, 41\u20138 (1988).","journal-title":"Circulation."},{"key":"26099_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.HYP.0000225424.13138.5d","volume":"48","author":"AF Mayer","year":"2006","unstructured":"Mayer, A. F. et al. Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension. 48, 120\u20136 (2006).","journal-title":"Hypertension."},{"key":"26099_CR15","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/ATVBAHA.111.244343","volume":"32","author":"R Bayles","year":"2012","unstructured":"Bayles, R. et al. Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol. 32, 1910\u20136 (2012).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"26099_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM200002243420803","volume":"342","author":"JR Shannon","year":"2000","unstructured":"Shannon, J. R. et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 342, 541\u20139 (2000).","journal-title":"N Engl J Med."},{"key":"26099_CR17","doi-asserted-by":"publisher","first-page":"e002674","DOI":"10.1161\/JAHA.115.002674","volume":"5","author":"K Heusser","year":"2005","unstructured":"Heusser, K. et al. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping. J Am Heart Assoc. 5, e002674 (2005).","journal-title":"J Am Heart Assoc."},{"key":"26099_CR18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1073\/pnas.1010122108","volume":"108","author":"M Baruscotti","year":"2011","unstructured":"Baruscotti, M. et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc Natl Acad Sci USA 108, 1705\u20131710 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"26099_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMoa052475","volume":"354","author":"R Milanesi","year":"2006","unstructured":"Milanesi, R., Baruscotti, M., Gnecchi-Ruscone, T. & DiFrancesco, D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med. 354, 151\u2013157 (2006).","journal-title":"N Engl J Med."},{"key":"26099_CR20","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehs391","volume":"34","author":"N Duhme","year":"2013","unstructured":"Duhme, N. et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur Heart J. 34, 2768\u20132775 (2013).","journal-title":"Eur Heart J."},{"key":"26099_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/jce.12974","volume":"27","author":"Z Abdel-Salam","year":"2016","unstructured":"Abdel-Salam, Z. & Nammas, W. Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence? J Cardiovasc Electrophysiol. 27, 670\u2013676 (2016).","journal-title":"J Cardiovasc Electrophysiol."},{"key":"26099_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2015.08.207","volume":"202","author":"G Caminiti","year":"2016","unstructured":"Caminiti, G., Fossati, C., Rosano, G. & Volterrani, M. Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance. Int. J. Cardiol. 202, 76\u201377 (2016).","journal-title":"Int. J. Cardiol."},{"key":"26099_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1540-8159.1983.tb05295.x","volume":"6","author":"P Coumel","year":"1983","unstructured":"Coumel, P., Friocourt, P., Mugica, J., Attuel, P. & Leclercq, J. F. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90\/minute: experience with 6 cases. Pacing Clin Electrophysiol. 6, 552\u2013560 (1983).","journal-title":"Pacing Clin Electrophysiol."},{"key":"26099_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM199102143240718","volume":"324","author":"J Leitch","year":"1991","unstructured":"Leitch, J., Klein, G., Yee, R., Murdick, C. & Teo, W. S. Neurally mediated syncope and atrial fibrillation. N Engl J Med. 324, 495\u2013496 (1991).","journal-title":"N Engl J Med."},{"key":"26099_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1085\/jgp.20028593","volume":"120","author":"A Bucchi","year":"2002","unstructured":"Bucchi, A., Baruscotti, M. & DiFrancesco, D. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol. 120, 1\u201313 (2002).","journal-title":"J Gen Physiol."},{"key":"26099_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1185\/030079905X50543","volume":"21","author":"D DiFrancesco","year":"2005","unstructured":"DiFrancesco, D. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents. Curr Med Res Opin. 21, 1115\u20131122 (2005).","journal-title":"Curr Med Res Opin."},{"key":"26099_CR27","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1038\/sj.emboj.7601868","volume":"26","author":"S Herrmann","year":"2007","unstructured":"Herrmann, S., Stieber, J., Stockl, G., Hofmann, F. & Ludwig, A. HCN4 provides a \u2018depolarization reserve\u2019 and is not required for heart rate acceleration in mice. Embo J. 26, 4423\u20134432 (2007).","journal-title":"Embo J."},{"key":"26099_CR28","doi-asserted-by":"publisher","unstructured":"Yaniv, Y. & Maltsev, V. A. Numerical modeling calcium and CaMKII effects in the SA node. Front Pharmacol. 5, 58, https:\/\/doi.org\/10.3389\/fphar.2014.00058 (2014).","DOI":"10.3389\/fphar.2014.00058"},{"key":"26099_CR29","doi-asserted-by":"publisher","first-page":"H594","DOI":"10.1152\/ajpheart.01118.2008","volume":"296","author":"VA Maltsev","year":"2009","unstructured":"Maltsev, V. A. & Lakatta, E. G. Synergism of coupled subsarcolemmal Ca2 clocks and sarcolemmal voltage clocks confers robust and flexible pacemaker function in a novel pacemaker cell model. Am J Physiol Heart Circ Physiol. 296, H594\u2013H615 (2009).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"26099_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.hrthm.2011.09.022","volume":"9","author":"VA Maltsev","year":"2012","unstructured":"Maltsev, V. A. & Lakatta, E. G. The funny current in the context of the coupled-clock pacemaker cell system. Heart Rhythm. 9, 302\u2013307 (2012).","journal-title":"Heart Rhythm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26099-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:32:44Z","timestamp":1671600764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26099-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26099"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26099-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"15 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7748"}}